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Abstract
The increasing incidence of postmenopausal osteoporosis and its related fractures have become global health issues in the
recent days. Postmenopausal osteoporosis is the most frequent metabolic bone disease; it is characterized by a rapid loss
of mineralized bone tissue. Hormone replacement therapy has proven efficacious in preventing bone loss but not desirable
to many women due to its side-effects. Therefore we are in need to search the natural compounds for a treatment of
postmenopausal symptoms in women with no toxic effects. In the present study, we have evaluated the effect of
petroleum-ether extract of Cissus quadrangularis Linn. (CQ), a plant used in folk medicine, on an osteoporotic rat model
developed by ovariectomy. In this experiment, healthy female Wistar rats were divided into four groups of six animals
each. Group 1 was sham operated. All the remaining groups were ovariectomized. Group 2 was fed with an equivolume of
saline and served as ovariectomized control (OVX). Groups 3 and 4 were orally treated with raloxifene (5.4 mg/kg) and
petroleum-ether extract of CQ (500 mg/kg), respectively, for 3 months. The findings were assessed on the basis of animal
weight, morphology of femur, and histochemical localization of alkaline phosphatase (ALP) (an osteoblastic marker) and
tartrate-resistant acid phosphatase (TRAP) (an osteoclastic marker) in upper end of femur. The study revealed for the
first time that the petroleum-ether extract of CQ reduced bone loss, as evidenced by the weight gain in femur, and also
reduced the osteoclastic activity there by facilitating bone formation when compared to the OVX group. The osteoclastic
activity was confirmed by TRAP staining, and the bone formation was assessed by ALP staining in the femur sections.
The color intensity of TRAP and ALP enzymes from the images were evaluated by image analysis software developed
locally. The effect of CQ was found to be effective on both enzymes, and it might be a potential candidate for prevention
and treatment of postmenopausal osteoporosis. The biological activity of CQ on bone may be attributed to the phytogenic
steroids present in it.
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Introduction
A substantial body of evidence indicates that osteo-
porosisisaglobalhealthproblemcharacterizedbythe
microarchitectural deterioration of bone mass and
strength that leads to fragility fractures, and
it is occurring in every geographic area, affecting
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DOI: 10.1080/03009730902891784150 million people worldwide. The most effective
treatment for the prevention of osteoporosis is hor-
mone replacement therapy. However, because of an
increased risk of breast cancer and an unacceptable
rate of undesirable outcomes, a large-scale clinical
intervention study was terminated early on the advice
of the Data and Safety Monitoring Board in the
United States (1). For quite a long time, estrogen,
bisphosphonates, calcitonin, calcium products, ipri-
flavone (2), and anabolic steroids have been used
clinically as effectivemedications. However, each one
of them is associated with numerous side-effects
(3,4). So active attempts still are being vigorously
pursued to identify new inhibitors of bone resorption
that minimize the necessity for drug therapy (4).
Traditional medicine has been widely used for thou-
sands of years to treat bone disorders. Although these
herbalmedicinesareseenascost-effectivealternatives
by their traditional users, their international accep-
tanceasamajorregimenforpreventionandtreatment
ofosteoporosiswouldrequireextensiveresearchusing
modernscience.Asapartofourcontinuingscreening
of biologically active antiosteoporotic agents, we
made an attempt to evaluate the effect of petroleum-
ether extract of Cissus quadrangularis Linn. (CQ) on
osteoporosis. CQ (Veldt Grape or Winged Treebine),
a climber in the family Vitaceae, is one of the most
frequently used medicinal plants in India and can be
foundthroughoutthecountry(5).Thefreshstemand
leaves of CQ are used for the treatment of various
ailments (622). Pharmacological studies have re-
vealed the bone fracture healing property (7,8) and
antiosteoporotic effect of this plant (13).
Shirwaikaretal.foundthat750mg/kgofbody-weight
of ethanolic extract given to rats was effective in
ovariectomy-inducedosteoporosis(13).Previousstu-
dies from our laboratory reported the effects of
ethanolic and petroleum-ether extract of CQ on
the ossification of fetal bone (2325).
In our quest to identify and isolate the active
principles of the CQ extract, we have more effectively
extractedspecificchemicalcompoundsfromtheplant
using different organic solvents and have tested these
extracts for their osteostimulant role in vitro. We have
observed that CQ petroleum-ether extract has a
pronounced effect on osteoblasts (unpublished
data). It was therefore pertinent to study the anti-
osteoporotic activity of petroleum-ether extract of
CQ, which has not been previously reported.
Materials and methods
Plant material and extraction
The stem of Cissus quadrangularis plant was collected
in the Nalgonda District of Andhra Pradesh, India,
identified and authenticated by a botanist, and a
voucher specimen was deposited in the pharmacol-
ogy department of the Manipal University, Manipal.
The fleshy stems (2.5 kg) were washed, cut into
small pieces, air-dried, and crushed into powder.
Stem powder was exhaustively extracted with 95%
ethanol using a Soxhlet apparatus. A yield of 225 g
was obtained. The total ethanol extract was con-
centrated in vacuum, the extract was dissolved in
water, and the solution was partitioned with petro-
leum-ether to obtain petroleum-ether extract in a
yield of 18.2 g.
Animals
A total of 114 (90 of both sexes, and 24 female)
3-month-old Wistar rats weighing approximately
225 g were housed in the central animal research
facility of Manipal University. The rats were housed
in sanitized polypropylene cages containing sterile
paddy husk as bedding. The animals were main-
tained under controlled conditions of temperature
(23928C), humidity (50%95%), and a 12-h light
dark cycle. All animals were allowed free access
to distilled water and fed on a commercial diet.
All the studies conducted were approved by the
Institutional Animal Ethical Committee (No. IAEC/
KMC/06/20062007), Kasturba Medical College,
Manipal, according to prescribed guide-lines of
the Committee for the Purpose of Control and
Supervision of Experiments on Animals (CPCSEA),
Government of India.
Acute toxicity studies
Acute toxicity was determined in fasting rats.
Animals were divided into groups of 10 each and
given orally 500, 1000, 1500, 2500, 3000, 3500,
4000, 4500, and 5000 mg/kg body-weight (bw) of
CQ. The rats were observed continuously for 2 h,
then, frequently up to 6 hours, and daily thereafter
for 30 days, and mortality if any was recorded (26).
Experimental protocol
After 7 days of acclimatization, the female Wistar
rats (24 in number) were ovariectomized or sham
operated. The rats were anesthetized with pentobar-
bital sodium (40 mg/kg bw, intra peritoneally (i.p.)),
and the ovaries were removed bilaterally. Sham
operation was performed in the same manner but
only exposing the ovaries (sham-operated (SHAM)
group). A week later, the ovariectomized rats were
randomly divided into 3 groups of six animals each.
The groups are: 1) sham operated (SHAM), 2)
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ted with 5.4 mg/kg bw of raloxifene (OVXRAL),
and 4) ovariectomized and treated with 500 mg/kg
bw of petroleum-ether extract of CQ (OVXCQ).
The treatment continued for 3 months. At the end of
the 3 months of treatment, rats in all groups were
weighed and sacrificed by cervical dislocation and
femur bones were dissected.
Measurement of femur length and weight
The femur length was measured as the distance
between the greater trochanter and the medial
condyle (27) in right femurs using vernier calipers.
The same femurs were then dried in an oven at
1108C for 48 h and weighed using a digital weighing
device.
Tissue processing for alkaline phosphatase (ALP), and
tartrate-resistant acid phosphatase (TRAP) staining
The left femurs were removed, dissected free of soft
tissue, and fixed with periodate-lysine-paraformal-
dehyde (PLP) fixative containing 2% paraformalde-
hyde, 0.075 M lysine, and 0.01 M sodium periodate
solution (pH 7.4, stored at 48C) for 24 h at 48Ca s
described previously (28). The bones were decalci-
fied by the protocol described previously (29,30).
Thereafter tissues were dehydrated in a graded series
of alcohols and embedded in paraffin wax. Care was
taken to ensure that all bones were oriented in
the same direction during embedding to minimize
differences in the angles at which the bones were
sectioned, and a single investigator processed all
bones to maintain consistency. The upper ends of
femurs were cut longitudinally at 5 mm thickness
in a rotary microtome and processed for alkaline
phosphatase (ALP) and tartrate-resistant acid phos-
phatase (TRAP) staining.
Histochemical localization of alkaline phosphatase
(ALP)
Bone sections were deparaffinized with xylene and
hydrated through graded alcohol series. The sections
were preincubated overnight in 1% magnesium
chloride in 100 mL Tris-maleate buffer (pH 9.2)
and then incubated for 2 h at room tempera-
ture in ALP substrate solution (freshly prepared
100 mM Tris-maleate buffer, pH 9.2, containing
0.2 mg/mL naphthol AS-MX phosphate (Sigma,
USA) and 0.4 mg/mL Fast Red TR (Sigma)). After
washing with distilled water, the sections were
counterstained with Vector methyl green nuclear
counterstain (Vector Laboratories, Peterborough,
UK) and mounted with Kaiser’s glycerol jelly (31).
Stained sections were photographed with a digital
camera attached to a binocular microscope. These
digital images were analyzed for ALP color intensity
using image analysis software developed locally.
Histochemical localization of tartrate-resistant acid
phosphatase (TRAP)
The sections were deparaffinized with xylene and
preincubated for 20 minutes in sodium acetate
Figure 1. Body-weight gain in sham control (SHAM), ovariecto-
mized (OVX), ovariectomized and raloxifene treated (OVX
RAL), and ovariectomized and Cissus quadrangularis extract
treated (OVXCQ) groups during 3 months treatment period.
Note the signiﬁcant increase in the body-weight gain in OVX
when compared to SHAM group (
+++PB0.001). The body-weight
is signiﬁcantly decreased when the OVX animals were treated with
CQ (
++PB0.01) and raloxifene (##PB0.01), respectively.
Table I. Femur weight and length. Femur weight and length in
sham control (SHAM), ovariectomized (OVX), ovariectomized
and raloxifene-treated (OVXRAL), and ovariectomized and
Cissus quadrangularis extract-treated (OVXCQ) groups. Note
there is a signiﬁcant decrease in the femur weight in the OVX
group compared to the SHAM group and a signiﬁcant increase in
the femur weight in the OVXRAL and OVXCQ groups
compared to the OVX Group. Also note that there is a slight
increase in the femur length in the OVX compared to the SHAM
group and a signiﬁcant decrease in the femur length in the OVX
RAL and OVXCQ groups compared to the OVX Group.
Group Femur weight (g) Femur length (mm)
SHAM 0.4990.008 31.690.170
OVX 0.3790.008
a 32.790.307
c
OVXRAL 0.4490.003
b 31.890.147
c
OVXCQ 0.4490.003
b 31.890.147
c
aPB0.001.
bPB0.001, one-way ANOVA, Bonferroni’s test.
cPB0.01.
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buffer (pH 5.0) and then incubated for a further
15 min at room temperature in the same buffer
containing naphthol AS-MX phosphate (2.5 mg/
mL) (Sigma) and fast garnet GBC (0.5 mg/mL)
(Sigma). After washing with distilled water, the
sections were counterstained with Vector methyl
green nuclear counterstain (Vector laboratories,
Peterborough, UK) and mounted in Kaiser’s gly-
cerol jelly (32). Stained sections were photographed
with a digital camera attached to a binocular
microscope. These digital images were analyzed for
TRAP color intensity using image analysis software
developed locally.
Image analysis
The images were analyzed using the in-house-
developed software named Tissue Quant 1.0. The
facility for choosing the particular color represent-
ing the maximum density of tissue as a reference
color is provided in the software. Using this facility,
the color setting was done for the analysis purpose.
The same setting was used for the analysis of all the
images.
The software assigns scores to the various shades
of the color represented by each pixel of the image,
based on how close the shade is to the reference
color. Using these values the total tissue present in
the image is quantified (33).
Figure 2. Histochemical localization of alkaline phosphatase in bone sections of sham control (SHAM), ovariectomized (OVX),
ovariectomized and raloxifene-treated (OVXRAL) and ovariectomized and treated with Cissus quadrangularis extract (OVXCQ) groups.
Note the signiﬁcant increase in the staining intensity in OVX, OVXRAL, OVXCQ groups compared to SHAM group.
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The results were expressed as the mean with the
standard error of mean. All data were analyzed
using Graphpad Prism software (Microsoft, San
Diego, CA, USA). One-way ANOVA was first
performed to test for any significant difference
among the groups. When significant, a post-test,
Bonferroni’s multiple comparison test was applied
to determine the specific difference between the
groups. The level of significance was PB0.05 for
all tests.
Results
Administration of the plant extract did not present
any adverse effect on the treated animals. All
animals were healthy throughout the experimental
period.
Effect of CQ on body-weight
The effect of CQ on the body-weights of all the
groups is presented in Figure 1. There was a
significant difference between the SHAM, OVX,
OVXRAL, and the OVXCQ-treated groups at
the end of the experimental period. The OVX rats
had a significant weight increase compared with
SHAM animals (PB0.001). The weight decreased
significantly compared with the OVX group after
treatment with raloxifene and CQ (PB0.01). With
respect to food consumption the animals in all the
groups had similar food.
Effect of CQ on femur weight and length
Ovariectomy resulted in a significant reduction
in femoral weight when compared with SHAM
group (PB0.001). Treatment with raloxifene and
CQ significantly increased the femoral weight and
brought it closer to the SHAM group (PB0.001,
Table I). There was a slight change in the femoral
length among the groups (Table I).
Effect of CQ on alkaline phosphatase activity in the bone
sections
The results of histochemical localization of ALP
of different groups studied are shown in Figures 2
and 3. As compared to group 1, group 2 animals
showed a significant rise in ALP levels (PB0.001)
at the end of 3 months following ovariectomy.
Group 3 and 4 showed a further increase in ALP
levels following administration of raloxifene and
CQ (PB0.001).
Effect of CQ on tartrate-resistant acid phosphatase
activity in the bone sections
The results of histochemical localization of TRAP of
different groups studied are shown in Figures 4 and
5. As compared to group 1, group 2 animals showed
a significant rise in TRAP levels (PB0.001) at the
end of 3 months following ovariectomy. Group 3 and
4 showed a significant decrease in TRAP levels
followed by administration of raloxifene and CQ.
Discussion
The current approach to the design of antiosteo-
porotic drugs is directed along the two basic
processes of bone remodeling. These are agents
aimed at preventing bone resorption (estrogen,
calcitonin, bisphosphonates, calcium, vitamin D,
raloxifene) and agents that stimulate bone forma-
tion (fluoride, anabolic steroids) (34). Among
these, estrogen replacement theraphy (ERT) used
to be a popular regime for prevention and treat-
ment of postmenopausal osteoporosis. However,
recent evidence suggests that ERT is associated
with increased risk of breast, ovarian, and endo-
metrial cancer (35,36). In addition, the most
frequently used antiosteoporotic drugs are devel-
oped in affluent countries, and the costs are too
high to benefit the ordinary people in developing or
even developed countries. Thus, alternative ap-
proaches for managing osteoporosis are needed.
The present study is the first to evaluate
the effect of petroleum-ether extract of CQ on
Figure 3. Alkaline phosphatase staining intensity score in bone
sections, measured using the software in sham control (SHAM),
ovariectomized (OVX), ovariectomized and raloxifene-treated
(OVXRAL), and ovariectomized and treated with Cissus quad-
rangularis plant extract (OVXCQ) groups. SHAM versus OVX:
+++PB0.001; SHAM versus OVXRAL: $$$PB0.001; SHAM
versus OVXCQ: ###PB0.001.
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known that estrogen deficiency is an important risk
factor in the pathogenesis of osteoporosis. Our
present study clearly demonstrated the usefulness
and beneficial effects of CQ in the treatment of
osteoporosis induced by ovariectomy. Estrogen in-
fluences bone loss either directly by binding to the
receptor on the bone or indirectly by influencing
calcium regulatory hormones (parathyroid hormone
(PTH) and vitamin D) and cytokines interleukin
(IL)-1 and Interleukin (IL)-6. Ovariectomy results
in a body-weight gain and a drastic decrease in bone
mineral density. These changes are mostly due to
estrogen deficiency.
The animals in the OVX group had a greater
body-weight gain compared with the other groups.
This weight gain due to ovariectomy despite similar
food consumption has been well documented (37).
Treatment with CQ and raloxifene reduced the
body-weight and increased the bone mass when
compared with the SHAM and the OVX animals;
this finding is of particular significance because it
Figure 4. Histochemical localization of tartrate-resistant acid phosphatase (TRAP) in bone sections of sham control (SHAM),
ovariectomized (OVX), ovariectomized and raloxifene-treated (OVXRAL) and ovariectomized and Cissus quadrangularis extract-treated
(OVXCQ) groups. Note the increased activity of TRAP in the OVX Group.
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synthesis of growth hormone (GH), which is known
to decrease the adipose tissue mass (38) and to
increase the bone mass (39). A slight increase in
femoral length could be observed in the OVX group
compared with the other groups, indicating the
effect of estrogen deficiency on the longitudinal
growth (40).
Our results clearly indicated that CQ extract
could suppress bone resorption induced by estrogen
deficiency. Tartrate-resistant acid phosphatase
(TRAP) is the most widely recognized marker for
bone resorption. Our data on histochemical localiza-
tion of TRAP supported that CQ and raloxifene
administration prevents elevation of TRAP occur-
ring due to ovarian hormone deficiency.
Alkaline phosphatase is an enzyme present in
many tissue cells like liver, kidney, intestine, pla-
centa, and germ cells and in osteoblasts. Bone ALP
has become the clinically most relevant enzyme in
the diagnosis of bone diseases. The ALP activity on
sections was seen more in the OVX group, due to
lack of inhibiting activity of estrogen on osteoclasts
causing the increase in bone resorption. Simulta-
neously with intensification of resorption process,
the bone formation process was also increased by
enhancement of osteoblast activity. It led to growth
of ALP activity in the OVX group (41), whereas in
CQ- and raloxifene-treated groups the ALP activity
was seen more than OVX. Since petroleum-ether
extract of CQ improved the activity of alkaline
phosphatase, the messenger initiating calcification,
it is possible that the herb accelerated mineralization
of the organic matrix, thus speeding up the bone
formation.
To our knowledge, the biological activity of CQ
on bone may be due to one or more of the
phytogenic steroids isolated, which are believed to
be the main constituent of CQ. Studies on fracture
healing suggested that the unidentified anabolic
steroid isolated by Sen (42) acts on estrogen
receptors of the bone cells. It also contains flavo-
noids, triterpenoids (4345) stilbene derivatives, and
many others, e.g. resveratrol, piceatannol, pallidol,
parthenocissine (4648), and phytosterols (49).
However, it remains unknown which particular
ingredient has effect on the above variables studied.
With all the above facts, the antiosteoporotic activity
of petroleum-ether extract of CQ may justifiably be
attributed to the steroids present in it, which
probably act as phytoestrogens to prevent the bone
loss (50).
Conclusion
The results obtained in the present study provide
evidence that CQ contributes importantly to the
prevention of bone loss induced by ovariectomy in
rats. However, in order to develop CQ extract in the
international scientific community as an alternative
regime for the treatment of bone diseases, more
research will be needed to identify the active
ingredients in CQ extract as well as the mechanism
that mediates the action of CQ extract in vivo.
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